Close Menu

NEW YORK – Twist Bioscience and China's Berry Genomics on Monday announced a partnership on next-generation sequencing target enrichment and library preparation tools.

Under their agreement, the firms will work together to develop new research and in vitro diagnostic NGS panels for inherited diseases.

Berry Genomics will also offer Twist's NGS panels for cancer diagnosis.

Financial and other details of the deal were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A small, early-stage trial of a combination therapy for brain cancer reports favorable responses in two patients, according to the Guardian.

Nature News writes that viral genomic surveillance in the US faces systemic issues.

President Joe Biden is seeking an increase in federal spending, including higher budgets for the National Institutes of Health and Centers for Disease Control and Prevention.

In PLOS this week: sex-stratified genome-wide association study of chronic pain, sequencing data from Indigenous Mexican groups, and more.